Frankfurt
08.08.25 | 08:08
0,130 Euro
-2,26 % -0,003
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Vext Science Inc: Vext receives dual-use provisional licence in Ohio | 2 | Stockwatch | ||
| 24.06. | VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield | 252 | Newsfile | Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail... ► Artikel lesen | |
| 16.06. | Vext Science Inc: Vext Science opens fifth dispensary in Ohio | 1 | Stockwatch | ||
| 16.06. | VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market | 277 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 06.06. | Vext Science Inc: Vext Science changes auditor to MNP | 1 | Stockwatch | ||
| 05.06. | VEXT Science, Inc.: Vext Announces Change of Auditor | 494 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 23.05. | Vext Science is a buy, Ventum Capital says | 3 | Cantech Letter | ||
| 21.05. | Vext Science reports Q1 results | 5 | Seeking Alpha | ||
| 21.05. | VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue | 389 | Newsfile | Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million... ► Artikel lesen | |
| 13.05. | Vext Science Inc: Vext Science to release Q1 2025 results May 21 | 5 | Stockwatch | ||
| 13.05. | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025 | 324 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 04.04. | Vext Science Inc: Vext unit to sell Kentucky cannabis processing licence | 2 | Stockwatch | ||
| 04.04. | VEXT Science, Inc.: Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License | 440 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertically integrated operations... ► Artikel lesen | |
| 03.04. | Vext Science Inc: Vext completes buy of two Ohio dispensaries | 3 | Stockwatch | ||
| 03.04. | VEXT Science, Inc.: Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries | 394 | Newsfile | Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open... ► Artikel lesen | |
| 01.04. | VEXT Science keeps buy rating at Ventum | 4 | Cantech Letter | ||
| 31.03. | Vext Science reports Q4 results | 3 | Seeking Alpha | ||
| 31.03. | VEXT Science, Inc.: Vext Delivers Solid Q4 Financial Results - Turning Point as Ohio Operations Gain Momentum | 239 | Newsfile | Q4 2024 marked Vext's strongest operating quarter in recent years, with growth across revenue, adjusted EBITDA, and cash flow.Revenue of $10.2 million in Q4 2024 (+13% QoQ), driven by Ohio adult-use... ► Artikel lesen | |
| 19.03. | Vext Science Inc: Vext Science to release 2024 results March 31 | 2 | Stockwatch | ||
| 19.03. | VEXT Science, Inc.: Vext to Announce Financial Results for Q4 and Fiscal 2024 on March 31, 2025 | 432 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,895 | +1,04 % | Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting | NASDAQ | TSX: ACB
EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada -based... ► Artikel lesen | |
| CANOPY GROWTH | 1,050 | -1,13 % | Stocks in Play: Canopy Growth Corporation | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,561 | +1,15 % | Tilray Brands: Gibt es doch Hoffnung? | Tilray Brands gehört zu den bekanntesten Cannabis-Unternehmen auf dem Markt, doch der Weg des Unternehmens war nach einer anfänglichen Hype-Phase in den letzten Jahren von branchentypisch starken Kursverlusten... ► Artikel lesen | |
| INNOCAN PHARMA | 0,128 | -1,54 % | Unglaubliche Prognose für Montag setzt Innocan Pharma Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| CRONOS GROUP | 1,957 | -1,11 % | Cronos Group Inc.: Cronos Group Reports 2025 Second Quarter Results | Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong... ► Artikel lesen | |
| SYNBIOTIC | 2,995 | +0,84 % | SynBiotic: Sportliche Ziele | Der Druck lässt nach. Die Chartmarke um 3 Euro scheint zu halten. Nach schwierigen Jahren hoffen die Aktionäre von SynBiotic momentan wieder auf bessere Zeiten. Unverkennbar: Daniel Kruse, der CEO des... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| ORGANIGRAM GLOBAL | 1,250 | +0,81 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen | |
| SNDL | 1,450 | +0,76 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,175 | +0,98 % | Green Thumb Industries Reports Second Quarter 2025 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| CRESCO LABS | 0,615 | -2,61 % | Cresco Labs Inc. Q2 Loss Narrows | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen |
Das Unternehmen VEXT SCIENCE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,26 % bei einem Aktienkurs von 0,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.